Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci (2015) 4.01

Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 3.46

Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease. Mov Disord (2016) 2.68

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64

Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology (2014) 2.10

Fiber tractography of the axonal pathways linking the basal ganglia and cerebellum in Parkinson disease: implications for targeting in deep brain stimulation. J Neurosurg (2014) 2.08

Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol (2011) 1.69

Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord (2011) 1.62

Return of bradykinesia after subthalamic stimulation ceases: relationship to electrode location. Exp Neurol (2011) 1.59

Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A (2014) 1.42

Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med (2012) 1.30

Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother (2010) 1.24

Deep brain stimulation for movement disorders. Front Integr Neurosci (2012) 1.24

Randomized controlled clinical trial of "virtual house calls" for Parkinson disease. JAMA Neurol (2013) 1.24

Effects of deep brain stimulation of the subthalamic nucleus on inhibitory and executive control over prepotent responses in Parkinson's disease. Front Syst Neurosci (2013) 1.22

Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology (2011) 1.21

Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry (2013) 1.20

Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg (2012) 1.15

Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease. Mov Disord (2015) 1.12

Diagnosis and treatment of common forms of tremor. Semin Neurol (2011) 1.08

Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease? Front Integr Neurosci (2012) 1.08

Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making. Brain (2012) 1.07

Closing the loop of deep brain stimulation. Front Syst Neurosci (2013) 1.07

Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest (2013) 1.07

Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol (2012) 1.01

Acute and Chronic Mood and Apathy Outcomes from a randomized study of unilateral STN and GPi DBS. PLoS One (2014) 1.01

The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg (2012) 0.99

Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. J Neurol (2014) 0.99

Deep brain stimulation: technology at the cutting edge. J Clin Neurol (2010) 0.97

Late-stage Parkinson disease. Nat Rev Neurol (2012) 0.97

Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? Neurotherapeutics (2016) 0.96

Progressive resistance exercise and Parkinson's disease: a review of potential mechanisms. Parkinsons Dis (2011) 0.96

The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. Parkinsonism Relat Disord (2013) 0.95

Upside down crossed cerebellar diaschisis: proposing chronic stimulation of the dentatothalamocortical pathway for post-stroke motor recovery. Front Integr Neurosci (2012) 0.95

Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci (2011) 0.94

Mechanisms of deep brain stimulation. J Neurophysiol (2015) 0.93

Review: management of Parkinson's disease. Neuropsychiatr Dis Treat (2013) 0.93

Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics (2014) 0.92

Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord (2012) 0.92

Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review. Front Neurol (2012) 0.92

Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis. Dysphagia (2014) 0.92

The effects of deep brain stimulation on sleep in Parkinson's disease. Ther Adv Neurol Disord (2011) 0.91

Site of deep brain stimulation and jaw velocity in Parkinson disease. J Neurosurg (2011) 0.91

Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg (2012) 0.90

STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice. Mov Disord Clin Pract (2014) 0.90

Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. J Neurol (2013) 0.90

Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease. Neurosci Biobehav Rev (2013) 0.90

Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches. Neurotherapeutics (2014) 0.89

Deep brain stimulation for movement disorders. Neurotherapeutics (2014) 0.89

Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci (2012) 0.87

Available and emerging treatments for Parkinson's disease: a review. Drug Des Devel Ther (2011) 0.87

Surgical treatment of dyskinesia in Parkinson's disease. Front Neurol (2014) 0.87

Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology (2014) 0.86

The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement. Front Neurol (2013) 0.86

Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features. Int J Environ Res Public Health (2015) 0.86

Subthalamic nucleus long-range synchronization-an independent hallmark of human Parkinson's disease. Front Syst Neurosci (2013) 0.85

Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection. Funct Neurol (2013) 0.85

Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders. Neuropsychiatr Dis Treat (2015) 0.85

Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation. Neurosci Biobehav Rev (2015) 0.85

Pediatric indications for deep brain stimulation. Childs Nerv Syst (2012) 0.85

Treatment of advanced Parkinson's disease. Curr Opin Neurol (2014) 0.85

Asymmetric right/left encoding of emotions in the human subthalamic nucleus. Front Syst Neurosci (2013) 0.84

The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. J Neurol (2013) 0.84

Timing of deep brain stimulation in Parkinson disease: a need for reappraisal? Ann Neurol (2013) 0.84

Weight change after globus pallidus internus or subthalamic nucleus deep brain stimulation in Parkinson's disease and dystonia. Stereotact Funct Neurosurg (2012) 0.84

Deep brain stimulation. Interv Neurol (2013) 0.84

Aggravated stuttering following subthalamic deep brain stimulation in Parkinson's disease--two cases. BMC Neurol (2011) 0.84

Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease. Neuron (2014) 0.83

Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease. J Neurol (2013) 0.83

Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus. Front Syst Neurosci (2011) 0.83

Deep brain stimulation of the subthalamic and pedunculopontine nucleus in a patient with Parkinson's disease. J Korean Neurosurg Soc (2015) 0.83

Quadruple deep brain stimulation in Huntington's disease, targeting pallidum and subthalamic nucleus: case report and review of the literature. J Neural Transm (Vienna) (2014) 0.83

Stimulation region within the globus pallidus does not affect verbal fluency performance. Brain Stimul (2012) 0.83

Transient and state modulation of beta power in human subthalamic nucleus during speech production and finger movement. Neuroscience (2011) 0.83

Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials. Clin Interv Aging (2016) 0.83

The effect of deep brain stimulation randomized by site on balance in Parkinson's disease. Mov Disord (2014) 0.83

Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? BMC Med (2013) 0.82

Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy? Ther Adv Neurol Disord (2012) 0.82

An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: Analysis of multiple databases. Parkinsonism Relat Disord (2016) 0.82

Movement disorders and neuromodulation. Neurol Res Int (2012) 0.82

The treatment of Parkinson's disease with deep brain stimulation: current issues. Neural Regen Res (2015) 0.82

Update on deep brain stimulation in Parkinson's disease. Transl Neurodegener (2015) 0.82

Parkinson's disease. Subcell Biochem (2012) 0.82

Shorter pulse generator longevity and more frequent stimulator adjustments with pallidal DBS for dystonia versus other movement disorders. Brain Stimul (2014) 0.82

Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature. J Neural Transm (Vienna) (2016) 0.81

Dopamine dysregulation syndrome and deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurol Res Int (2011) 0.81

Pallidal deep brain stimulation relieves camptocormia in primary dystonia. J Neurol (2013) 0.81

Deep brain stimulation in Parkinson's disease. Transl Neurodegener (2013) 0.81

Beyond Mere Symptom Relief in Deep Brain Stimulation: An Ethical Obligation for Multi-faceted Assessment of Outcome. AJOB Neurosci (2012) 0.81

Intraoperative electrocorticography for physiological research in movement disorders: principles and experience in 200 cases. J Neurosurg (2016) 0.80

Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson's Disease. J Mov Disord (2015) 0.80

Moving to music: effects of heard and imagined musical cues on movement-related brain activity. Front Hum Neurosci (2014) 0.80

Recent advances in the assessment and treatment of falls in Parkinson's disease. F1000 Med Rep (2010) 0.80

Compensatory stepping in Parkinson's disease is still a problem after deep brain stimulation randomized to STN or GPi. J Neurophysiol (2015) 0.80

Anatomical targets associated with abrupt versus gradual washout of subthalamic deep brain stimulation effects on bradykinesia. PLoS One (2014) 0.80

Effects of neurostimulation for advanced Parkinson's disease patients on motor symptoms: A multiple-treatments meta-analysas of randomized controlled trials. Sci Rep (2016) 0.79

Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety. Degener Neurol Neuromuscul Dis (2012) 0.79

Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments. J Neurol (2015) 0.79

The anatomy of the caudal zona incerta in rodents and primates. J Anat (2013) 0.79

Surgical treatment of Parkinson disease: past, present, and future. Neurol Clin (2013) 0.79

Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70

Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17

Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43

A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol (2004) 11.42

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA (2009) 8.40

Coronary-artery revascularization before elective major vascular surgery. N Engl J Med (2004) 7.80

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry (2007) 6.80

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71

Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: a randomized clinical trial. JAMA (2006) 6.34

Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med (2010) 6.21

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia (2010) 5.64

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol (2006) 5.49

Amiodarone versus sotalol for atrial fibrillation. N Engl J Med (2005) 5.01

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron (2002) 4.77

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60

Mouse brain organization revealed through direct genome-scale TF expression analysis. Science (2004) 4.55

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47

Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain (2007) 4.36

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol (2008) 4.16

A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol (2010) 3.84

Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol (2005) 3.78

Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med (2015) 3.67

Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke (2006) 3.67

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55

High-frequency oscillations and seizure generation in neocortical epilepsy. Brain (2004) 3.53

Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 3.46

The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg (2002) 3.44

Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39

3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33

Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.29

Identification of competence pheromone responsive genes in Streptococcus pneumoniae by use of DNA microarrays. Mol Microbiol (2004) 3.29

Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates. Nat Neurosci (2004) 3.26

The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry (2005) 3.24

Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.24

Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol (2006) 3.02

Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet (2002) 2.90

Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ (2004) 2.86

Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA (2013) 2.82

Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care (2007) 2.78

Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry (2009) 2.76

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ (2003) 2.74

Identifying patient preoperative risk factors and postoperative adverse events in administrative databases: results from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Am Coll Surg (2002) 2.73

Dementia with Lewy bodies. Lancet Neurol (2004) 2.66

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol (2009) 2.60

Comparison of laparoscopic and open repair with mesh for the treatment of ventral incisional hernia: a randomized trial. Arch Surg (2010) 2.58

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord (2006) 2.53

Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA (2011) 2.52

Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry (2007) 2.52